体外膜氧合（ECMO）设备市场－全球产业规模、份额、趋势、机会、预测：按组件类型、模式、病患类型、应用、地区和竞争格局划分，2021-2031年

全球体外膜氧合（ECMO）设备市场预计将从 2025 年的 4.4163 亿美元成长到 2031 年的 5.9692 亿美元，复合年增长率为 5.15%。

体外膜氧合（ECMO）设备作为重要的维生系统，为心肺功能受损的患者提供长期的呼吸和心臟辅助。市场成长的主要驱动因素包括严重心血管和呼吸系统疾病（例如急性呼吸窘迫症候群）发病率的上升，以及老龄化人口对高阶重症监护解决方案的需求不断增长。根据体外生命支持组织（ELSO）的数据，到2024年，註册患者人数将超过20万，这表明该疗法在治疗危及生命的健康问题方面正得到越来越广泛的应用。

儘管需求强劲，但体外膜氧合（ECMO）治疗费用高昂，且有感染疾病和出血等临床风险，这些都构成了重大障碍。此外，ECMO还需要专门的基础设施和进阶培训，这些挑战严重阻碍了ECMO的广泛应用，尤其是在缺乏充足资金和技术专长的医疗机构中。

市场驱动因素

呼吸系统和心血管疾病发生率的不断上升是全球体外膜氧合（ECMO）设备市场成长的主要驱动力。随着急性呼吸窘迫症候群和心臟衰竭等疾病发病率的不断攀升，临床上对机械循环支持的需求日益迫切。其影响十分显着；根据美国心臟协会于2024年1月发布的《2024年心臟病和中风统计数据》，约48.6%的美国成年人将患有某种形式的心血管疾病。这一现实迫使医疗机构采用先进的生命维持系统来满足不断增长的患者群体，并加速了ECMO作为移植和復健关键桥樑的需求。

同时，体外心肺復苏术（CPR）技术的日益普及和专业重症监护设施的扩建也支撑着市场的发展势头。这一上升趋势反映在主要市场参与企业的财务表现中，显示设备使用量整体呈现成长趋势。例如，Livanova在2024年5月发布的2024年第一季财报中显示，其心肺復苏部门的营收年增14.8%，显示这些治疗方法得到了迅速推广。更广泛的行业数据也印证了这一成长趋势。 Terumo Terumo Corporation在2024年5月发布的截至2024年3月的财年合併会计显示，其总收入同比增长12.4%，凸显了其商业规模的扩大以及对这些关键医疗技术的持续投资。

市场挑战

体外膜氧合（ECMO）疗法的高昂成本和显着的临床风险是限制全球市场扩张的主要障碍。医疗机构不仅需要承担购买这些先进设备的巨额费用，还需要资金筹措来维护专业设施和高技能的多学科团队。这些经济障碍使得小规模、资源有限的医疗机构几乎无法采用这项技术，导致该市场主要局限于大型医疗机构。

此外，由于严重併发症发生率高，这种疗法仍是最后的选择，而非标准治疗方案。近期数据凸显了高风险患者族群生存保障的挑战，也强调了临床疗效的不稳定性。根据体外生命支持系统（ELSO）2024年发布的国际註册报告，接受体外心肺復苏术的成年患者的出院存活率仅29.5%。如此低的生存率进一步强化了该手术风险极高的观点，促使临床医生在选择患者时更加谨慎，从而导致全球范围内手术数量减少。

市场趋势

轻量、紧凑、可携式膜氧合（ECMO）系统的研发正在从根本上改变市场格局。这使得高级生命支持能够突破固定三级医疗机构的限制。这些小型化设备能够安全地在医院间转运严重病人，并有效实施「中心辐射式」模式，即由小规模医疗机构先稳定病人病情，然后再将其转运至专科医院。这种向便携化发展的趋势解决了传统大规模主机在运输方面面临的挑战，并拓展了现场应用范围和地理覆盖范围。美国外科医师学会于2025年9月发表的一篇报导《ECMO：从罕见的救命选择到切实可行的方案》的文章指出，一项美国计画调查发现，在274家成人ECMO中心中，目前有63家提供行动服务，这表明医疗机构正在迅速投资于运输基础设施，以改善患者的医疗就途径。

同时，人工智慧 (AI) 在即时预测分析中的应用正在透过提高临床决策的准确性，彻底改变患者照护。製造商正在加速将机器学习演算法整合到体外膜氧合 (ECMO) 设备中，以解读复杂的生理数据，从而在氧合器故障和血栓形成等併发症发展到危险阶段之前，儘早识别它们。这项技术进步正在将治疗模式从被动的、以维持为主的治疗方法转变为主动的、精准的医疗策略，从而直接应对与该手术相关的高死亡风险。 Integration Health 在 2025 年 4 月发布的报告《人工智慧与 ECMO：重症监护死亡率预测的未来》中强调了这一潜力，该报告指出，经过检验的AI 模型在预测静脉-动脉 ECMO 患者 28 天死亡风险方面达到了 93% 以上的准确率，为临床医生提供了一个强大的工具，用于优化治疗方案和患者选择。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：体外膜氧合装置的全球市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依组件类型（帮浦、氧合器、控制器、插管、附件）
  • 特定模式（静脉-动脉、静脉-静脉、动脉-静脉）
  • 依患者类型（新生儿、儿童、成人）
  • 依应用领域（呼吸系统、心臟系统、体外心肺復苏术）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美体外膜氧合（ECMO）设备市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国别分析
  • 我们
  • 加拿大
  • 墨西哥

第七章：欧洲体外膜氧合设备市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国别分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区体外膜氧合设备市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国别分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲体外膜氧合设备市场展望

• 市场规模及预测
• 市占率及预测
• 中东与非洲：国别分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲体外膜氧合设备市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国别分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 促进因素
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 近期趋势

第十三章 全球体外膜氧合（ECMO）设备市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的议价能力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• India Medtronic Private Limited
• Terumo Cardiovascular Systems Corporation
• MAQUET Holding BV & Co. KG
• Medos Medizintechnik AG
• Nipro Medical Corporation
• MicroPort Scientific Corporation
• XENIOS AG
• LivaNova PLC
• EUROSETS Srl

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Extracorporeal Membrane Oxygenation Machine Market is projected to expand from USD 441.63 Million in 2025 to USD 596.92 Million by 2031, registering a compound annual growth rate of 5.15%. An Extracorporeal Membrane Oxygenation (ECMO) machine functions as a critical life-support apparatus, offering extended respiratory and cardiac assistance to patients with compromised heart and lung function. Market growth is chiefly driven by the increasing incidence of severe cardiovascular and respiratory conditions, such as acute respiratory distress syndrome, coupled with an aging demographic that demands advanced critical care solutions. Data from the Extracorporeal Life Support Organization reveals that by 2024, the registry had cumulatively enrolled more than 200,000 patients, highlighting the broadening adoption of this therapy for life-threatening health issues.

Despite this robust demand, the market encounters substantial obstacles related to the significant expenses and clinical dangers associated with ECMO interventions, including infection and hemorrhage. When coupled with the requirement for specialized infrastructure and extensive training, these issues form major impediments to widespread adoption, especially in medical facilities lacking significant financial capability or technical proficiency.

Market Driver

The escalating frequency of respiratory and cardiovascular disorders acts as the main engine for growth in the Global Extracorporeal Membrane Oxygenation Machine Market. With the rising occurrence of ailments like acute respiratory distress syndrome and heart failure, the clinical requirement for mechanical circulatory support is becoming increasingly urgent. The impact is significant; the American Heart Association's 'Heart Disease and Stroke Statistics-2024 Update' from January 2024 reveals that approximately 48.6% of adults in the United States suffer from some type of cardiovascular disease. This reality forces healthcare institutions to adopt sophisticated life-support systems to treat this expanding patient demographic, thereby stimulating the need for ECMO as a crucial bridge to transplantation or recovery.

Concurrently, market momentum is being sustained by the growing implementation of extracorporeal cardiopulmonary resuscitation and the broadening of specialized critical care facilities. This upward trend is mirrored in the financial results of key market participants, indicating a general increase in device usage. For example, LivaNova reported in its 'First Quarter 2024 Results' in May 2024 that revenue for its Cardiopulmonary division rose by 14.8% year-over-year, demonstrating the rapid adoption of these treatments. This expansion is further supported by broader industry figures; Terumo Corporation's 'Consolidated Financial Results for the Fiscal Year Ended March 31, 2024', released in May 2024, showed a 12.4% annual increase in total revenue, emphasizing the substantial commercial scale and ongoing investment in these essential care technologies.

Market Challenge

The significant financial expenses and considerable clinical dangers linked to Extracorporeal Membrane Oxygenation procedures act as major impediments to the global market's expansion. Medical centers must contend with heavy costs, not only for the initial purchase of these sophisticated devices but also for the continuous funding required for specialized facilities and highly skilled multidisciplinary teams. These economic barriers effectively prevent resource-constrained or smaller healthcare institutions from adopting the technology, consequently limiting the market's potential client base primarily to large medical hubs.

Additionally, the frequency of severe complications restricts the use of this therapy to a measure of last resort rather than a standard option. The volatility of clinical outcomes is underscored by recent data showing the challenges in securing survival among high-risk patient cohorts. As per the Registry International Report released by the Extracorporeal Life Support Organization in 2024, the survival-to-discharge rate for adults undergoing extracorporeal cardiopulmonary resuscitation was merely 29.5 percent. Such modest survival rates solidify the view of the procedure as a precarious undertaking, prompting clinicians to be extremely selective with patients, which ultimately suppresses the global volume of procedures.

Market Trends

The market is undergoing a fundamental transformation due to the development of lightweight, compact transportable ECMO systems, which allow advanced life support to extend beyond stationary tertiary care environments. These miniaturized units enable the safe transfer of critically ill patients between hospitals, effectively implementing a "hub-and-spoke" model where smaller clinics can stabilize patients prior to moving them to specialized facilities. This evolution toward portability resolves the logistical challenges posed by older, bulky consoles, broadening the technology's application in the field and its geographic reach. According to an article by the American College of Surgeons titled 'ECMO Expands from Rare Rescue to Real Option' in September 2025, a survey of U.S. programs indicated that 63 out of 274 adult ECMO centers now provide mobile services, signifying rapid investment in transport infrastructure to enhance patient access.

At the same time, the incorporation of artificial intelligence for real-time predictive analytics is revolutionizing patient care by improving the precision of clinical decisions. Manufacturers are increasingly integrating machine learning algorithms into ECMO devices to interpret complex physiological data, allowing for the early identification of complications like oxygenator failure or clot formation before they reach a critical stage. This technological advancement transitions the therapy from a reactive maintenance approach to a proactive precision medicine strategy, directly addressing the high mortality risks linked to the procedure. This potential was highlighted by Integration Health in their April 2025 report 'AI and ECMO: The Future of Mortality Prediction in Critical Care', which noted that a validated AI model achieved over 93% accuracy in predicting 28-day mortality risk in Veno-Arterial ECMO patients, providing clinicians with a robust tool for optimizing care plans and patient selection.

Key Market Players

• India Medtronic Private Limited
• Terumo Cardiovascular Systems Corporation
• MAQUET Holding B.V. & Co. KG
• Medos Medizintechnik AG
• Nipro Medical Corporation
• MicroPort Scientific Corporation
• XENIOS AG
• LivaNova PLC
• EUROSETS S.r.l.

Report Scope

In this report, the Global Extracorporeal Membrane Oxygenation Machine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Extracorporeal Membrane Oxygenation Machine Market, By Component Type

• Pumps
• Oxygenator
• Controllers
• Cannula
• Accessories

Extracorporeal Membrane Oxygenation Machine Market, By Modality

• Veno-Arterial
• Veno-Venous
• Arterio-Venous

Extracorporeal Membrane Oxygenation Machine Market, By Patient Type

• Neonates
• Pediatric
• Adult

Extracorporeal Membrane Oxygenation Machine Market, By Application

• Respiratory
• Cardiac
• ECPR

Extracorporeal Membrane Oxygenation Machine Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Extracorporeal Membrane Oxygenation Machine Market.

Available Customizations:

Global Extracorporeal Membrane Oxygenation Machine Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Extracorporeal Membrane Oxygenation Machine Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Component Type (Pumps, Oxygenator, Controllers, Cannula, Accessories)
  • 5.2.2. By Modality (Veno-Arterial, Veno-Venous, Arterio-Venous)
  • 5.2.3. By Patient Type (Neonates, Pediatric, Adult)
  • 5.2.4. By Application (Respiratory, Cardiac, ECPR)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Extracorporeal Membrane Oxygenation Machine Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Component Type
  • 6.2.2. By Modality
  • 6.2.3. By Patient Type
  • 6.2.4. By Application
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Extracorporeal Membrane Oxygenation Machine Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Component Type
      • 6.3.1.2.2. By Modality
      • 6.3.1.2.3. By Patient Type
      • 6.3.1.2.4. By Application
  • 6.3.2. Canada Extracorporeal Membrane Oxygenation Machine Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Component Type
      • 6.3.2.2.2. By Modality
      • 6.3.2.2.3. By Patient Type
      • 6.3.2.2.4. By Application
  • 6.3.3. Mexico Extracorporeal Membrane Oxygenation Machine Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Component Type
      • 6.3.3.2.2. By Modality
      • 6.3.3.2.3. By Patient Type
      • 6.3.3.2.4. By Application

7. Europe Extracorporeal Membrane Oxygenation Machine Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Component Type
  • 7.2.2. By Modality
  • 7.2.3. By Patient Type
  • 7.2.4. By Application
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Extracorporeal Membrane Oxygenation Machine Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Component Type
      • 7.3.1.2.2. By Modality
      • 7.3.1.2.3. By Patient Type
      • 7.3.1.2.4. By Application
  • 7.3.2. France Extracorporeal Membrane Oxygenation Machine Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Component Type
      • 7.3.2.2.2. By Modality
      • 7.3.2.2.3. By Patient Type
      • 7.3.2.2.4. By Application
  • 7.3.3. United Kingdom Extracorporeal Membrane Oxygenation Machine Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Component Type
      • 7.3.3.2.2. By Modality
      • 7.3.3.2.3. By Patient Type
      • 7.3.3.2.4. By Application
  • 7.3.4. Italy Extracorporeal Membrane Oxygenation Machine Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Component Type
      • 7.3.4.2.2. By Modality
      • 7.3.4.2.3. By Patient Type
      • 7.3.4.2.4. By Application
  • 7.3.5. Spain Extracorporeal Membrane Oxygenation Machine Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Component Type
      • 7.3.5.2.2. By Modality
      • 7.3.5.2.3. By Patient Type
      • 7.3.5.2.4. By Application

8. Asia Pacific Extracorporeal Membrane Oxygenation Machine Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Component Type
  • 8.2.2. By Modality
  • 8.2.3. By Patient Type
  • 8.2.4. By Application
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Extracorporeal Membrane Oxygenation Machine Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Component Type
      • 8.3.1.2.2. By Modality
      • 8.3.1.2.3. By Patient Type
      • 8.3.1.2.4. By Application
  • 8.3.2. India Extracorporeal Membrane Oxygenation Machine Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Component Type
      • 8.3.2.2.2. By Modality
      • 8.3.2.2.3. By Patient Type
      • 8.3.2.2.4. By Application
  • 8.3.3. Japan Extracorporeal Membrane Oxygenation Machine Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Component Type
      • 8.3.3.2.2. By Modality
      • 8.3.3.2.3. By Patient Type
      • 8.3.3.2.4. By Application
  • 8.3.4. South Korea Extracorporeal Membrane Oxygenation Machine Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Component Type
      • 8.3.4.2.2. By Modality
      • 8.3.4.2.3. By Patient Type
      • 8.3.4.2.4. By Application
  • 8.3.5. Australia Extracorporeal Membrane Oxygenation Machine Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Component Type
      • 8.3.5.2.2. By Modality
      • 8.3.5.2.3. By Patient Type
      • 8.3.5.2.4. By Application

9. Middle East & Africa Extracorporeal Membrane Oxygenation Machine Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Component Type
  • 9.2.2. By Modality
  • 9.2.3. By Patient Type
  • 9.2.4. By Application
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Extracorporeal Membrane Oxygenation Machine Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Component Type
      • 9.3.1.2.2. By Modality
      • 9.3.1.2.3. By Patient Type
      • 9.3.1.2.4. By Application
  • 9.3.2. UAE Extracorporeal Membrane Oxygenation Machine Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Component Type
      • 9.3.2.2.2. By Modality
      • 9.3.2.2.3. By Patient Type
      • 9.3.2.2.4. By Application
  • 9.3.3. South Africa Extracorporeal Membrane Oxygenation Machine Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Component Type
      • 9.3.3.2.2. By Modality
      • 9.3.3.2.3. By Patient Type
      • 9.3.3.2.4. By Application

10. South America Extracorporeal Membrane Oxygenation Machine Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Component Type
  • 10.2.2. By Modality
  • 10.2.3. By Patient Type
  • 10.2.4. By Application
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Extracorporeal Membrane Oxygenation Machine Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Component Type
      • 10.3.1.2.2. By Modality
      • 10.3.1.2.3. By Patient Type
      • 10.3.1.2.4. By Application
  • 10.3.2. Colombia Extracorporeal Membrane Oxygenation Machine Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Component Type
      • 10.3.2.2.2. By Modality
      • 10.3.2.2.3. By Patient Type
      • 10.3.2.2.4. By Application
  • 10.3.3. Argentina Extracorporeal Membrane Oxygenation Machine Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Component Type
      • 10.3.3.2.2. By Modality
      • 10.3.3.2.3. By Patient Type
      • 10.3.3.2.4. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Extracorporeal Membrane Oxygenation Machine Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. India Medtronic Private Limited
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Terumo Cardiovascular Systems Corporation
• 15.3. MAQUET Holding B.V. & Co. KG
• 15.4. Medos Medizintechnik AG
• 15.5. Nipro Medical Corporation
• 15.6. MicroPort Scientific Corporation
• 15.7. XENIOS AG
• 15.8. LivaNova PLC
• 15.9. EUROSETS S.r.l.

16. Strategic Recommendations

17. About Us & Disclaimer